These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19537846)

  • 1. Biomarkers in amyotrophic lateral sclerosis: facts and future horizons.
    Pradat PF; Dib M
    Mol Diagn Ther; 2009; 13(2):115-25. PubMed ID: 19537846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New biological and radiological markers in amyotrophic lateral sclerosis].
    Pradat PF
    Presse Med; 2009 Dec; 38(12):1843-51. PubMed ID: 19386463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyotrophic lateral sclerosis: objective upper motor neuron markers.
    Kaufmann P; Mitsumoto H
    Curr Neurol Neurosci Rep; 2002 Jan; 2(1):55-60. PubMed ID: 11898584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Objective markers for upper motor neuron involvement in amyotrophic lateral sclerosis].
    Iwata NK
    Brain Nerve; 2007 Oct; 59(10):1053-64. PubMed ID: 17969345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions.
    Mori F; Tada M; Kon T; Miki Y; Tanji K; Kurotaki H; Tomiyama M; Ishihara T; Onodera O; Kakita A; Wakabayashi K
    Acta Neuropathol Commun; 2019 Oct; 7(1):165. PubMed ID: 31661037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased expression of Myosin binding protein H in the skeletal muscle of amyotrophic lateral sclerosis patients.
    Conti A; Riva N; Pesca M; Iannaccone S; Cannistraci CV; Corbo M; Previtali SC; Quattrini A; Alessio M
    Biochim Biophys Acta; 2014 Jan; 1842(1):99-106. PubMed ID: 24184715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis.
    Nakane S; Fujita K; Azuma S; Urushihara R; Kamada M; Harada M; Izumi Y; Kaji R
    Clin Neurol Neurosurg; 2018 Sep; 172():162-168. PubMed ID: 30016754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is magnetic resonance imaging a plausible biomarker for upper motor neuron degeneration in amyotrophic lateral sclerosis/primary lateral sclerosis or merely a useful paraclinical tool to exclude mimic syndromes? A critical review of imaging applicability in clinical routine.
    Rocha AJ; Maia Júnior AC
    Arq Neuropsiquiatr; 2012 Jul; 70(7):532-9. PubMed ID: 22836461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 in differential diagnosis of motor neuron disorders.
    Dickson DW; Josephs KA; Amador-Ortiz C
    Acta Neuropathol; 2007 Jul; 114(1):71-9. PubMed ID: 17569066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A prognostic biomarker in amyotrophic lateral sclerosis].
    Mitsumoto H; Saito T
    Rinsho Shinkeigaku; 2018 Dec; 58(12):729-736. PubMed ID: 30487362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated imaging of [
    Ratai EM; Alshikho MJ; Zürcher NR; Loggia ML; Cebulla CL; Cernasov P; Reynolds B; Fish J; Seth R; Babu S; Paganoni S; Hooker JM; Atassi N
    Neuroimage Clin; 2018; 20():357-364. PubMed ID: 30112276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TDP-43 levels are higher in platelets from patients with sporadic amyotrophic lateral sclerosis than in healthy controls.
    Hishizawa M; Yamashita H; Akizuki M; Urushitani M; Takahashi R
    Neurochem Int; 2019 Mar; 124():41-45. PubMed ID: 30578840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biomarkers for amyotrophic lateral sclerosis].
    Tokuda T
    Brain Nerve; 2012 May; 64(5):515-23. PubMed ID: 22570065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Steinacker P; Hendrich C; Sperfeld AD; Jesse S; von Arnim CA; Lehnert S; Pabst A; Uttner I; Tumani H; Lee VM; Trojanowski JQ; Kretzschmar HA; Ludolph A; Neumann M; Otto M
    Arch Neurol; 2008 Nov; 65(11):1481-7. PubMed ID: 19001167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43
    Weerasekera A; Crabbé M; Tomé SO; Gsell W; Sima D; Casteels C; Dresselaers T; Deroose C; Van Huffel S; Rudolf Thal D; Van Damme P; Himmelreich U
    Neuroimage Clin; 2020; 27():102327. PubMed ID: 32653817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a TDP-43-Based Biomarker for ALS and FTLD.
    Feneberg E; Gray E; Ansorge O; Talbot K; Turner MR
    Mol Neurobiol; 2018 Oct; 55(10):7789-7801. PubMed ID: 29460270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis.
    Sorarú G; Orsetti V; Buratti E; Baralle F; Cima V; Volpe M; D'ascenzo C; Palmieri A; Koutsikos K; Pegoraro E; Angelini C
    Amyotroph Lateral Scler; 2010; 11(1-2):240-3. PubMed ID: 19306141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined use of conventional MRI and MR spectroscopic imaging increases the diagnostic accuracy in amyotrophic lateral sclerosis.
    Cervo A; Cocozza S; Saccà F; Giorgio SMDA; Morra VB; Tedeschi E; Marsili A; Vacca G; Palma V; Brunetti A; Quarantelli M
    Eur J Radiol; 2015 Jan; 84(1):151-157. PubMed ID: 25466774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
    Collins MA; An J; Hood BL; Conrads TP; Bowser RP
    J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers in amyotrophic lateral sclerosis.
    Turner MR; Kiernan MC; Leigh PN; Talbot K
    Lancet Neurol; 2009 Jan; 8(1):94-109. PubMed ID: 19081518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.